View this email in your browser

Keep the government out of pharmaceutical drug manufacturing
The Orange County Register | Sally C. Pipes
September 12, 2020

If government-sponsored manufacturers entered the market, they’d likely have minimal impact. They could even lose money. California taxpayers are surely unenthused about seeding a new state-run drug company with $1 million to $2 million start-up capital and hundreds of thousands of dollars in operating funds, only to see their “investment” go up in smoke.



MarketWatch Features Dr. Henry Miller Comments on COVID-19 Vaccine Trials
MarketWatch | Jaimy Lee
September 14, 2020

Whether you’re new to investing in pharmaceutical or biotechnology companies or simply paying close attention to the race to develop a COVID-19 vaccine, questions may have occurred about how clinical trials work — here’s what you need to know to understand the process.



Medicare for none – these are the reforms we need to keep program solvent
Fox News | Sally C. Pipes
September 14, 2020

That’s among the conclusions to draw from a new Congressional Budget Office report. The agency now projects that Medicare’s Part A hospital insurance trust fund will run out of cash in just four years – two years earlier than previous estimates.



Blanket lockdowns for coronavirus are poor policy
Featured in the Buffalo News | Sally C. Pipes
September 9, 2020

Delaying a cancer diagnosis for just a month can considerably reduce patients’ chances of survival. Ned Sharpless, director of the National Cancer Institute, conservatively estimates that delayed screenings will result in 10,000 additional cancer deaths over the next decade.
Watch the Latest "Escape the Drug Pricing Maze Video"
Making the Entire Health Care System More Affordable – 3 Keys to Reform Drug Pricing System, Part 3

As the Professor and Pete search for the final key to escape the drug pricing maze, they visit the City of Free Enterprise and learn that reforms to make the entire health care system more affordable are critical to making prescription drugs more accessible and affordable. To learn more, visit www.medecon.org
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104



Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.